Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 24 Sep 2026
Diagnosis complicated by absence of radiologic evidence of hepatic lesions
Read Full NewsThe FDA has approved asundexian, the first factor XIa inhibitor indicated to reduce recurrent stroke after a noncardioembolic ischemic stroke or high-risk TIA, based on phase 3 OCEANIC-STROKE data.
An analysis of the PROSPECT trial reported that consistent use of transcutaneous afferent patterned stimulation was associated with improvement in underlying tremor severity in patients with essential tremor.
A study of deceased former NFL players estimated that nearly 75% had CTE neuropathology, while a phase 3 trial is evaluating whether F-18 FNT-PET imaging could help identify disease-associated patterns in living patients.
Odinachi Oguh, MD, movement disorder specialist at the Cleveland Clinic Lou Ruvo Center for Brain Health, shares clinical perspectives on biomarkers, aging, non-motor symptoms, and prodromal disease from the 2026 MDS Congress.
At a NeurologyLive Clinical Forum in New York, Mary Ann Piccone, MD, of Holy Name Medical Center, led a wide-ranging discussion among MS specialists on the limits of current high-efficacy therapies, the pipeline of emerging agents, and the gap between physician and patient treatment priorities.
Rezpegaldesleukin's Early Treg Signal in AD: Emma Guttman-Yassky, MD
Omalizumab Biosimilar CT-P39: Quality of Life Gains Precede CSU Control
1.
Proton Therapy Fails to Beat IMRT in Prostate Cancer
2.
Liver Failure or Liver Mets?
3.
FDA Warns of Secondary Blood Cancer Risk With Tazverik
4.
November 2023, Medical Bulletin 04/.
5.
Brigatinib Makes Its Case for ALK-Positive ALCL in Small Study
1.
Colorectal Cancer Incidence Trends: A Growing Concern in 2024 and 2025
2.
Microfluidic Bone Marrow Harvesting Devices: Revolutionizing Hematopoietic Stem Cell Collection
3.
Engineered Immune Cells for Brain Tumors: Mechanisms, Clinical Impact, and Future Directions
4.
Mastering Modern Oncology: Accreditation, Education, and Research Trends for 2025
5.
Colorectal Cancer Uncovered: CME, Case Studies, and Clinical Strategies
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Cancer screening: Test that can help detect cancer early
2.
Early warning sings of camcer that need medical attention
3.
The Role of Emotional Support During Cancer Recovery
4.
Preventing Blood Clots: The Importance of Venous Thromboembolism Management
5.
ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge